Food-dependent disintegration of immediate release fosamprenavir tablets: In vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system

被引:80
作者
Brouwers, Joachim [1 ]
Anneveld, Bart [2 ]
Goudappel, Gert-Jan [3 ]
Duchateau, Guus [3 ]
Annaert, Pieter [1 ]
Augustijns, Patrick [1 ]
Zeijdner, Evelijn [2 ]
机构
[1] Katholieke Univ Leuven, Lab Pharmacotechnol & Biopharm, BE-3000 Louvain, Belgium
[2] TNO Qual Life, Zeist, Netherlands
[3] Unilever Res Labs, Vlaardingen, Netherlands
关键词
Formulation development; Immediate release tablets; Tablet disintegration; Fed state; Magnetic resonance imaging; TNO gastrointestinal model; DISSOLUTION; AMPRENAVIR; BEHAVIOR; STOMACH; PRODRUG; PLASMA;
D O I
10.1016/j.ejpb.2010.10.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, we demonstrated the value of two advanced tools, the TNO gastric and small Intestinal Model (TIM-1) and magnetic resonance imaging (MRI), for the in vitro evaluation of food-dependent disintegration of immediate release fosamprenavir tablets. Upon introduction of a tablet with the nutritional drink Scandishake Mix (R) in the stomach compartment of TIM-1, simulating the fed state, disintegration and fosamprenavir dissolution were significantly postponed compared to the fasted state (lag time 80 +/- 23 min). This resulted in a lag in the appearance of bioaccessible fosamprenavir (<5% during the first 2 h), even though the nutritional state did not significantly alter the cumulative bioaccessibility after 5 h. These results were in agreement with the previously observed postprandial delay in gastric fosamprenavir tablet disintegration and subsequent amprenavir absorption in healthy volunteers. Therefore. TIM-1 can be used in tablet development to identify food-induced disintegration issues causing unexpected clinical behavior. From a mechanistic perspective, we applied MRI to illustrate impaired water ingress in fosamprenavir tablets immersed in the nutritional drink compared to simulated gastric fluid. This effect may be attributed to both competition between nutritional components and the tablet for the available water (indicated by reduced rotational and translational diffusion) as well as the possible formation of a food-dependent precipitation layer on the HPMC-coated tablet. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 16 条
  • [1] Food effects on tablet disintegration
    Abrahamsson, B
    Albery, T
    Eriksson, A
    Gustafsson, I
    Sjöberg, M
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (2-3) : 165 - 172
  • [2] A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions
    Blanquet, S
    Zeijdner, E
    Beyssac, E
    Meunier, JP
    Denis, S
    Havenaar, R
    Alric, M
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (04) : 585 - 591
  • [3] Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state
    Brouwers, Joachim
    Tack, Jan
    Augustijns, Patrick
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (10) : 1862 - 1869
  • [4] In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: Illustration of intraluminal supersaturation
    Brouwers, Joachim
    Tack, Jan
    Augustijns, Patrick
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (02) : 302 - 309
  • [5] Davenport H.W., 1977, PHYSL DIGESTIVE TRAC, V4
  • [6] ELASHOFF JD, 1982, GASTROENTEROLOGY, V83, P1306
  • [7] Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir
    Furfine, ES
    Baker, CT
    Hale, MR
    Reynolds, DJ
    Salisbury, JA
    Searle, AD
    Studenberg, SD
    Todd, D
    Tung, RD
    Spaltenstein, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) : 791 - 798
  • [8] Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses
    Garbacz, Grzegorz
    Wedemeyer, Ralph-Steven
    Nagel, Stefan
    Giessmann, Thomas
    Moennikes, Hubert
    Wilson, Clive G.
    Siegmund, Werner
    Weitschies, Werner
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) : 421 - 428
  • [9] HAVENAAR R, 1994, Patent No. 9300225
  • [10] Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update
    Jantratid, Ekarat
    Janssen, Niels
    Reppas, Christos
    Dressman, Jennifer B.
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (07) : 1663 - 1676